Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001984921 | SCV002212711 | pathogenic | Familial meningioma | 2021-08-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln230*) in the SMARCE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMARCE1 are known to be pathogenic (PMID: 23377182). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SMARCE1-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. |